Off Patent
May 2027

Aveed

testosterone undecanoate

Endo Operations Ltd

Injectable (intramuscular) · NDA 022219

Last listed protection ends
May 8, 2027

The FDA lists 2 patents for Aveed, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 7,718,640
    Claims the drug product
  2. Patent 8,338,395
    Claims a use (U-1500)